Error loading player: No playable sources found

Player size: small large

Targeting PI3K-gamma with IPI-549, a Tumor Macrophage-Reprogramming Small Molecule, in Patients with Advanced Solid Tumors

Date

September 23, 2020

Speaker

Brenda C. O'Connell, PhD

Infinity Pharmaceuticals, Inc

Tracks

Targeting Myeloid Cells in Cancer Therapy II

Related Products

Thumbnail for Mechanisms Governing Accumulation of Macrophages in Cancer

Mechanisms Governing Accumulation of Macrophages in Cancer

Thumbnail for Differentiating Macrophages are Regulated by PARP Inhibitors and can be Harnessed to Overcome PARP-Inhibitor Resistance in BRCA-Associated Triple-Negative Breast Cancer

Differentiating Macrophages are Regulated by PARP Inhibitors and can be Harnessed to Overcome PARP-Inhibitor Resistance in BRCA-Associated Triple-Negative Breast Cancer

Thumbnail for Short Talk: Extracellular Vesicles Derived from a Commensal Bacteria Enhance Anticancer Immunity by Modulating Tumor Infiltrating Immune Cells

Short Talk: Extracellular Vesicles Derived from a Commensal Bacteria Enhance Anticancer Immunity by Modulating Tumor Infiltrating Immune Cells

Thumbnail for Targeting Myeloid Cells in Cancer Therapy II

Targeting Myeloid Cells in Cancer Therapy II

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.